1. Medtech Insight
  2. >>Minute Insights

Minute Insight: Real-World Data Supports Medtronic’s 780G Insulin Pump

 
• By Reed Miller

Postmarket data from Europe and Chile, announced at the American Diabetes Association conference, offer more support for Medtronic’s faith in its MiniMed 780G system with the Guardian 4 sensor.

Minute Insight
• Source: Informa/Alamy

“Real-world” experience with Medtronic’s MiniMed 780G system with the Guardian 4 sensor, presented at the American Diabetes Association (ADA) meeting in New Orleans, affirm the encouraging results from the randomized ADAPT trial of the 780G system.

Preliminary results from ADAPT, announced last month, showed type 1 diabetes patients using the 780G system had a better a time in range – ­the percentage of time during which the users' glucose levels are in the target range – than patients relying on multiple daily insulin injections. ADAPT also showed the 780G system helped users reduce their HbA1c levels over six months

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

LSX Europe: Women’s Health Education Is The Key For Unlocking VC Investment

 
• By Natasha Barrow

Flo Health was the first femtech unicorn to be valued at over $1bn. But the company faced 49 investment rejections before reaching that status, Anna Klepchukova, the company’s chief medical officer, told the LSX World Congress Europe. THENA Capital’s Esther Reynal de St Michel Richardot talked through the firm’s gender-smart investment strategy.

Synchron And Apple Team Up To Use ‘Mind-Thought Connection’ To Control iPhones, iPads

 
• By Marion Webb

Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 
• By Natasha Barrow

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.